Relative Risk of High-Grade Cervical Disease in women 25–29 years old with NILM or ASCUS or worse cytology and in women 30–55 years old with NILM or ASCUS or worse cytology.

HPV = human papilloma virus; HR-HPV = high-risk HPV types; NILM = negative for intraepithelial lesion or malignancy; ASCUS = atypical squamous cells of undetermined significance; 14HR HPV(−) = HPV DNA test negative for the pooled 14 high-risk types; 14HR HPV(+) = HPV DNA test positive for the pooled 14 high-risk types; 12HR HPV(−) = HPV DNA test negative for the pooled 12 high-risk types except 16 and 18; 12HR HPV(+) = HPV DNA test positive for the pooled 12 high-risk types except 16 and 18; HPV16(+) = HPV DNA test positive for HPV 16; HPV18(+) = HPV DNA test positive for HPV 18; HPV16(+)/HPV18(+) = HPV DNA test positive for HPV16 and HPV18; HRHPV(+)/HPV16(+) = HPV DNA test positive for the pooled 12 high-risk types except 16 and 18 and for HPV16; HRHPV(+)/HPV18(+) = HPV DNA test positive for the pooled 12 high-risk types except 16 and 18 and for HPV18; CIN2 = Cervical Intraepithelial Neoplasia grade 2
Relative Risk of High-Grade Cervical Disease in women 25–29 years old with NILM or ASCUS or worse cytology and in women 30–55 years old with NILM or ASCUS or worse cytology.